Literature DB >> 11786568

Accuracy of recorded tumor, node, and metastasis stage in a comprehensive cancer center.

James D Brierley1, Pamela A Catton, Brian O'Sullivan, Janet E Dancey, Anthony J Dowling, Jonathan C Irish, Thomas S McGowan, Jeremy F G Sturgeon, Carol J Swallow, George B Rodrigues, Tony Panzarella.   

Abstract

PURPOSE: The benefits of recording the tumor, node, and metastasis (TNM) stages of cancer patients are well accepted, but little is known about how accurately this is performed. An audit was performed to determine the accuracy of recorded stage and to act as a baseline before the implementation of an education program. PATIENTS AND METHODS: All new patient referrals to Princess Margaret Hospital between July 1 and August 31, 1997, were reviewed. An audit panel composed of five health record technicians (HRTs) and 10 doctors was assembled. Each auditor reviewed 10% of the health record. If there was a discrepancy between the stage in the health record and the auditor stage, then the final stage was determined by the audit committee. Analysis of the agreement between the health record, the physician auditor, the HRT auditor, and the final stage was performed.
RESULTS: A total of 855 patients were referred with a new diagnosis of a malignancy for which there was a TNM stage system; 833 patients (97.4%) had a stage assigned. There was agreement between the health record stage and final stage in 80% (95% confidence interval [CI], 77% to 82%) of cases for clinical stage, compared with 90% (95% CI, 87% to 92%) for pathologic stage. Of the major site groups, lung was the least accurately recorded. The most common major discrepancies were due to the recording of X when a definite category could be assigned.
CONCLUSION: This audit demonstrates the importance of staging and provides impetus to develop staging guidelines and education programs.

Entities:  

Mesh:

Year:  2002        PMID: 11786568     DOI: 10.1200/JCO.2002.20.2.413

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  7 in total

1.  The importance of precise pT diagnosis for prognostic prediction of uterine cervical cancer--a single institutional report at a Japanese comprehensive cancer hospital.

Authors:  Norihiro Teramoto; Rieko Nishimura; Koichi Mandai; Takashi Matsumoto; Takamitsu Nogawa; Masamichi Hiura
Journal:  Virchows Arch       Date:  2009-09-24       Impact factor: 4.064

2.  Staging systems for papillary thyroid carcinoma: a study of 2 tertiary referral centers.

Authors:  Brian Hung-Hin Lang; Sin-Ming Chow; Chung-Yau Lo; Stephen C K Law; King-Yin Lam
Journal:  Ann Surg       Date:  2007-07       Impact factor: 12.969

3.  Clinical significance of KAI1/CD82 protein expression in nasopharyngeal carcinoma.

Authors:  Gengming Wang; Hao Jiang; Hongbo Xu; Qian Sun; Yan Zhou; Ping Xiang; Zenong Cheng; Yajun Zhang; Yufu Zhou; Qing Guo; Xinglong DU; Shuxiu Xu; Shiyin Ma; Zhendong Chen
Journal:  Oncol Lett       Date:  2015-01-23       Impact factor: 2.967

4.  TNM-O: ontology support for staging of malignant tumours.

Authors:  Martin Boeker; Fábio França; Peter Bronsert; Stefan Schulz
Journal:  J Biomed Semantics       Date:  2016-11-14

5.  Modification of the TNM Staging System for Stage II/III Gastric Cancer Based on a Prognostic Single Patient Classifier Algorithm.

Authors:  Yoon Young Choi; Eunji Jang; Won Jun Seo; Taeil Son; Hyoung-Il Kim; Hyeseon Kim; Woo Jin Hyung; Yong-Min Huh; Sung Hoon Noh; Jae-Ho Cheong
Journal:  J Gastric Cancer       Date:  2018-05-31       Impact factor: 3.720

6.  Clinical audit of multidisciplinary care at a medium-sized hospital in Spain.

Authors:  Ana Ruiz-Casado; María Jesús Ortega; Ana Soria; Héctor Cebolla
Journal:  World J Surg Oncol       Date:  2014-03-06       Impact factor: 2.754

7.  Molecular Predictors for Advanced Papillary Thyroid Carcinoma Recurrence.

Authors:  Taciana Padilha de Castro; Ricardo Cortez Cardoso Penha; Luisa Aguirre Buexm; Flávia Nascimento de Carvalho; Raquel de Vasconcellos Carvalhaes Oliveira; Fernando Vaz Agarez; Luciana Wernersbach Pinto; Denise P Carvalho
Journal:  Front Endocrinol (Lausanne)       Date:  2019-12-05       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.